Methylphenidate treatment of negative symptoms in patients with dementia



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Galynker, I.
	Articles by Rosenthal, R.
	Search for Related Content



	PubMed Citation
	Articles by Galynker, I.
	Articles by Rosenthal, R.

J Neuropsychiatry Clin Neurosci 1997; 9:231-239
Copyright © 1997 by American Neuropsychiatric Association

REGULAR ARTICLES

Methylphenidate treatment of negative symptoms in patients with dementia

I Galynker, C Ieronimo, C Miner, J Rosenblum, N Vilkas and R Rosenthal
Milton and Carroll Petrie Division, Beth Israel Medical Center, New York, NY 10003, USA.

This pilot study evaluated response of negative symptoms (NS) to methylphenidate in patients with dementia and relationships between NS, depression, and cognitive deficits in these patients. Consecutively admitted patients with NS and dementia--12 with dementia of Alzheimer's type and 15 with vascular dementia--were rated on severity of NS (SANS and PANSS-N scales), depressive symptoms (Ham-D), and cognitive impairment (MMSE) before and after treatment with methylphenidate. NS decreased significantly, and cognitive scores increased. A decrease in depression scores was nonsignificant after all variance attributable to NS was removed. NS, depression, and cognitive scores were not significantly intercorrelated. Results were similar for Alzheimer's and vascular dementia patients. Negative symptoms in dementia patients appear responsive to methylphenidate treatment. This effect may underlie putative changes in symptoms of depression observed by other researchers.

This article has been cited by other articles:

K. L. Lanctot, N. Herrmann, S. E. Black, M. Ryan, L. S. Rothenburg, B. A. Liu, and U. E. Busto
Apathy Associated with Alzheimer Disease: Use of Dextroamphetamine Challenge
Am J Geriatr Psychiatry, July 1, 2008; 16(7): 551 - 557.
[Abstract] [Full Text] [PDF]

L. Massimo and M. Grossman
Patient Care and Management of Frontotemporal Lobar Degeneration
American Journal of Alzheimer's Disease and Other Dementias, May 1, 2008; 23(2): 125 - 131.
[Abstract] [PDF]

P. R. Padala, W. J. Burke, S. C. Bhatia, and F. Petty
Treatment of Apathy With Methylphenidate
J Neuropsychiatry Clin Neurosci, February 1, 2007; 19(1): 81 - 83.
[Abstract] [Full Text] [PDF]

Y.-H. Kim, M.-H. Ko, S.-Y. Na, S.-H. Park, and K.-W. Kim
Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study
Clinical Rehabilitation, January 1, 2006; 20(1): 24 - 30.
[Abstract] [PDF]

R. van Reekum, D. T. Stuss, and L. Ostrander
Apathy: Why Care?
J Neuropsychiatry Clin Neurosci, February 1, 2005; 17(1): 7 - 19.
[Abstract] [Full Text] [PDF]

N. Herrmann, K. L. Lanctot, and L. R. Khan
The Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia
J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 261 - 276.
[Abstract] [Full Text] [PDF]

Get information about faster international access.